Novo Integrated Sciences, Inc. NVOS
0.00
0.00
NaN
as of 24 Sep
- Market cap
- $730.0K
- P/E
- 0.0×
Follow NVOS
Growth Flags
show if company had growth for consecutive years
| Older periods | Nov '23 | Feb '24 | May '24 | Aug '24 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(63.50%) | (49.47%) | (135.33%) | (82.67%) | |
| (37.23%) | (33.83%) | (68.46%) | (47.76%) | ||
ROIC |
(26.49%) | (26.28%) | (71.21%) | (42.44%) | |
Return on Tangible Assets |
(1,163.58%) | (3,945.22%) | 214.21% | 398.81% | |
Average Days of Receivables |
103.08 | 85.58 | 88.98 | 86.54 | |
Free Cash Flow per Share |
(0.25) | (0.28) | (0.26) | (0.28) | |
Free Cash Flow |
(4.12) | (4.95) | (4.80) | (5.12) | |
Capital Expenditures |
— | — | (0.05) | (0.05) | |
Piotroski F-Score |
5.00 | 3.00 | 3.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(15.84%) | (20.97%) | (38.73%) | (30.67%) | |
Accounts Receivable Turnover |
4.58 | 5.28 | 4.77 | 4.69 | |
Accounts Payable Turnover |
2.88 | 3.87 | 2.91 | 2.24 | |
Inventory Turnover |
6.92 | 8.70 | 8.21 | 7.17 | |
Average Days of Payables |
157.52 | 97.38 | 168.75 | 156.39 | |
Days of Inventory on Hand |
58.81 | 42.44 | 48.19 | 48.37 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
113.36% | 109.04% | 115.15% | 105.73% | |
Share Based Compensation of Revenue |
20.26% | 17.05% | 12.40% | 8.99% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.30 | 0.41 | 0.20 | 0.31 | |
Depreciation/Fixed assets |
1.25 | 0.96 | 1.50 | 1.73 | |
Capex/Depreciation |
0.00 | 0.00 | (0.01) | (0.01) | |
Revenue per Share |
0.78 | 0.77 | 0.72 | 0.74 | |
Operating CF per Share |
(0.25) | (0.28) | (0.25) | (0.28) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(107.02%) | (88.48%) | (179.99%) | (121.61%) |
Columns are period end dates